Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Titel:
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Auteur:
Rossello, Xavier Piñero, Antonio Fernández-Jiménez, Rodrigo Sánchez-González, Javier Pizarro, Gonzalo Galán-Arriola, Carlos Lobo-Gonzalez, Manuel Vilchez, Jean Paul García-Prieto, Jaime García-Ruiz, Jose Manuel García-Álvarez, Ana Sanz-Rosa, David Ibanez, Borja